Mydecine Innovations Group

BioTech/Drugs - Denver, CO, US

Mydecine Innovations Group Details

Mydecine Innovations Group™ (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) is a biotechnology company developing innovative first- and second-generation novel therapeutics for the treatment of mental health and addiction through world-class technology and drug development infrastructure. The company's world-renowned medical and scientific advisory board is progressing a robust research and development (R&D) pipeline of psychedelic derived therapeutics, novel compounds, therapies, and controlled drug delivery systems.

Mydecine Innovations Group logo, Mydecine Innovations Group contact details
Website: mydecine.com
Employees: 20 - 49
HQ: N/A
Location: Denver, CO, US
Revenue: 2.5 - 5 Million
Biotechnology
Mydecine Innovations Group Technologies
Email Providers

Gmail

Load Balancers

Apache

Hosting

Amazon AWS

Other

Mobile Friendly

View All Technologies Used At Mydecine Innovations Group

Contacting Mydecine Innovations Group: Connect with Executives and Employees

Get in Touch with Mydecine Innovations Group Executives and Employees

Connecting with Mydecine Innovations Group's Executives and Workforce

Accessing Contact Information for Mydecine Innovations Group Executives

Connecting with Mydecine Innovations Group: Reach Out to Their Team

Discover How to Contact Mydecine Innovations Group Executives and Staff

Looking to connect with Mydecine Innovations Group executives or employees?

Seeking to Get in Touch with Mydecine Innovations Group Executives or Staff?

Want to Reach Out to Mydecine Innovations Group Executives or Team Members?

In Search of Contact Details for Mydecine Innovations Group Professionals?

Connecting with Mydecine Innovations Group: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z